Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2014

Open Access 01-12-2014 | Research

Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control study

Authors: Oscar J Pozo, Josep Marcos, Andreu Fabregat, Rosa Ventura, Gregori Casals, Paula Aguilera, Jordi Segura, Jordi To-Figueras

Published in: Orphanet Journal of Rare Diseases | Issue 1/2014

Login to get access

Abstract

Background

Acute Intermittent Porphyria (AIP) is a rare disease that results from a deficiency of hydroxymethylbilane synthase, the third enzyme of the heme biosynthetic pathway. AIP carriers are at risk of presenting acute life-threatening neurovisceral attacks. The disease induces overproduction of heme precursors in the liver and long-lasting deregulation of metabolic networks. The clinical history of AIP suggests a strong endocrine influence, being neurovisceral attacks more common in women than in men and very rare before puberty. To asses the hypothesis that steroidogenesis may be modified in AIP patients with biochemically active disease, we undertook a comprehensive analysis of the urinary steroid metabolome.

Methods

A case–control study was performed by collecting spot morning urine from 24 AIP patients and 24 healthy controls. Steroids in urine were quantified by liquid chromatography-tandem mass spectrometry. Parent steroids (17-hydroxyprogesterone; deoxycorticosterone; corticoesterone; 11-dehydrocorticosterone; cortisol and cortisone) and a large number of metabolites (N = 55) were investigated. Correlations between the different steroids analyzed and biomarkers of porphyria biochemical status (urinary heme precursors) were also evaluated. The Mann–Whitney U test and Spearman’s correlation with a two tailed test were used for statistical analyses.

Results

Forty-one steroids were found to be decreased in the urine of AIP patients (P < 0.05), the decrease being more significant for steroids with a high degree of hydroxylation. Remarkably, 13 cortisol metabolites presented lower concentrations among AIP patients (P < 0.01) whereas no significant differences were found in the main metabolites of cortisol precursors. Nine cortisol metabolites showed a significant negative correlation with heme precursors (p < 0.05). Ratios between the main metabolites of 17-hydroxyprogesterone and cortisol showed positive correlations with heme-precursors (correlation coefficient > 0.51, P < 0.01).

Conclusions

Comprehensive study of the urinary steroid metabolome showed that AIP patients present an imbalance in adrenal steroidogenesis, affecting the biosynthesis of cortisol and resulting in decreased out-put of cortisol and metabolites. This may result from alterations of central origin and/or may originate in specific decreased enzymatic activity in the adrenal gland. An imbalance in steroidogenesis may be related to the maintenance of an active disease state among AIP patients.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Anderson KE, Sassa SS, Bishop DF, Desnick RJ: Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. The metabolic basis of inherited disease. 8th edition. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill; 2001. Anderson KE, Sassa SS, Bishop DF, Desnick RJ: Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. The metabolic basis of inherited disease. 8th edition. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill; 2001.
3.
go back to reference Elder G, Harper P, Badminton M, Sandberg S, Deybach JC: The incidence of inherited porphyrias in Europe. J Inherit Metab Dis. 2013, 36 (5): 849-857. 10.1007/s10545-012-9544-4.CrossRefPubMed Elder G, Harper P, Badminton M, Sandberg S, Deybach JC: The incidence of inherited porphyrias in Europe. J Inherit Metab Dis. 2013, 36 (5): 849-857. 10.1007/s10545-012-9544-4.CrossRefPubMed
4.
go back to reference Kauppinen R, Mustajoki P: Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine (Baltimore). 1992, 71: 1-13.CrossRef Kauppinen R, Mustajoki P: Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine (Baltimore). 1992, 71: 1-13.CrossRef
5.
go back to reference Hift RJ, Meissner PN: An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria. Medicine (Baltimore). 2005, 84: 48-60. 10.1097/01.md.0000152454.56435.f3.CrossRef Hift RJ, Meissner PN: An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria. Medicine (Baltimore). 2005, 84: 48-60. 10.1097/01.md.0000152454.56435.f3.CrossRef
6.
go back to reference Thunell S: Outside the box: genomic approach to acute porphyria. Physiol Res. 2006, 55: 43-66. Thunell S: Outside the box: genomic approach to acute porphyria. Physiol Res. 2006, 55: 43-66.
7.
go back to reference Meyer UA, Schuurmans MM, Lindberg RL: Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis. 1998, 18: 43-52. 10.1055/s-2007-1007139.CrossRefPubMed Meyer UA, Schuurmans MM, Lindberg RL: Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis. 1998, 18: 43-52. 10.1055/s-2007-1007139.CrossRefPubMed
8.
go back to reference Marsden JT, Rees D: Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria. J Clin Pathol. 2014, 67: 60-65. 10.1136/jclinpath-2012-201367.CrossRefPubMed Marsden JT, Rees D: Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria. J Clin Pathol. 2014, 67: 60-65. 10.1136/jclinpath-2012-201367.CrossRefPubMed
9.
go back to reference Soonawalla ZF, Orug T, Badminton MN, Elder GH, Rhodes JM, Bramhall SR, Elias E: Liver transplantation as a cure for acute intermittent porphyria. Lancet. 2004, 363: 705-706. 10.1016/S0140-6736(04)15646-8.CrossRefPubMed Soonawalla ZF, Orug T, Badminton MN, Elder GH, Rhodes JM, Bramhall SR, Elias E: Liver transplantation as a cure for acute intermittent porphyria. Lancet. 2004, 363: 705-706. 10.1016/S0140-6736(04)15646-8.CrossRefPubMed
10.
go back to reference Anderson KE, Spitz IM, Sassa S, Bardin CW, Kappas A: Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone releasing hormone. N Engl J Med. 1984, 311: 643-645. 10.1056/NEJM198409063111006.CrossRefPubMed Anderson KE, Spitz IM, Sassa S, Bardin CW, Kappas A: Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone releasing hormone. N Engl J Med. 1984, 311: 643-645. 10.1056/NEJM198409063111006.CrossRefPubMed
11.
go back to reference Deybach JC, Casamitjana R, Puy H, Herrero C: Role of two nutritional hepatic markers (insulin-like growth factor 1 and transthyretin) in the clinical assessment and follow-up of acute intermittent porphyria patients. J Intern Med. 2009, 266: 277-285. 10.1111/j.1365-2796.2009.02118.x.CrossRefPubMed Deybach JC, Casamitjana R, Puy H, Herrero C: Role of two nutritional hepatic markers (insulin-like growth factor 1 and transthyretin) in the clinical assessment and follow-up of acute intermittent porphyria patients. J Intern Med. 2009, 266: 277-285. 10.1111/j.1365-2796.2009.02118.x.CrossRefPubMed
12.
go back to reference Casals G, Marcos J, Pozo OJ, Aguilera P, Herrero C, To-Figueras J: Gas chromatography–mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria. Clin Biochem. 2013, 46 (9): 819-824. 10.1016/j.clinbiochem.2013.03.001.CrossRefPubMed Casals G, Marcos J, Pozo OJ, Aguilera P, Herrero C, To-Figueras J: Gas chromatography–mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria. Clin Biochem. 2013, 46 (9): 819-824. 10.1016/j.clinbiochem.2013.03.001.CrossRefPubMed
13.
go back to reference Larion S, Caballes FR, Hwang SI, Lee JG, Rossman WE, Parsons J, Steuerwald N, Li T, Maddukuri V, Groseclose G, Finkielstein CV, Bonkovsky HL: Circadian rhythms in acute intermittent porphyria–a pilot study. Eur J Clin Invest. 2013, 43 (7): 727-739. 10.1111/eci.12102.CrossRefPubMedPubMedCentral Larion S, Caballes FR, Hwang SI, Lee JG, Rossman WE, Parsons J, Steuerwald N, Li T, Maddukuri V, Groseclose G, Finkielstein CV, Bonkovsky HL: Circadian rhythms in acute intermittent porphyria–a pilot study. Eur J Clin Invest. 2013, 43 (7): 727-739. 10.1111/eci.12102.CrossRefPubMedPubMedCentral
14.
go back to reference Aarsand AK, Villanger JH, Støle E, Deybach JC, Marsden J, To-Figueras J, Badminton M, Elder GH, Sandberg S: European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Clin Chem. 2011, 57 (11): 1514-1523. 10.1373/clinchem.2011.170357.CrossRefPubMed Aarsand AK, Villanger JH, Støle E, Deybach JC, Marsden J, To-Figueras J, Badminton M, Elder GH, Sandberg S: European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Clin Chem. 2011, 57 (11): 1514-1523. 10.1373/clinchem.2011.170357.CrossRefPubMed
15.
go back to reference To-Figueras J, Badenas C, Carrera C, Muñoz C, Mila M, Lecha M, Herrero C: Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation. J Inherit Metab Dis. 2006, 29 (4): 580-585. 10.1007/s10545-006-0344-6.CrossRefPubMed To-Figueras J, Badenas C, Carrera C, Muñoz C, Mila M, Lecha M, Herrero C: Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation. J Inherit Metab Dis. 2006, 29 (4): 580-585. 10.1007/s10545-006-0344-6.CrossRefPubMed
16.
go back to reference Marsden JT, Chowdhury P, Wang J, Deacon A, Dutt N, Peters TJ, Macdougall IC: Acute intermittent porphyria and chronic renal failure. Clin Nephrol. 2008, 69 (5): 339-346. 10.5414/CNP69339.CrossRefPubMed Marsden JT, Chowdhury P, Wang J, Deacon A, Dutt N, Peters TJ, Macdougall IC: Acute intermittent porphyria and chronic renal failure. Clin Nephrol. 2008, 69 (5): 339-346. 10.5414/CNP69339.CrossRefPubMed
17.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999, 130 (6): 461-10.7326/0003-4819-130-6-199903160-00002.CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999, 130 (6): 461-10.7326/0003-4819-130-6-199903160-00002.CrossRefPubMed
18.
go back to reference Marcos J, Renau N, Casals G, Segura J, Ventura R, Pozo OJ: Investigation of endogenous corticosteroids profiles in human urine based on liquid chromatography tandem mass spectrometry. Anal Chim Acta. 2014, 812: 92-104.CrossRefPubMed Marcos J, Renau N, Casals G, Segura J, Ventura R, Pozo OJ: Investigation of endogenous corticosteroids profiles in human urine based on liquid chromatography tandem mass spectrometry. Anal Chim Acta. 2014, 812: 92-104.CrossRefPubMed
19.
go back to reference Miller WL, Auchus RJ: The molecular biology, biochemistry and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011, 32 (1): 81-151. 10.1210/er.2010-0013.CrossRefPubMedPubMedCentral Miller WL, Auchus RJ: The molecular biology, biochemistry and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011, 32 (1): 81-151. 10.1210/er.2010-0013.CrossRefPubMedPubMedCentral
20.
go back to reference Weykamp CW, Penders TJ, Schmidt NA, Borburgh AJ, van de Calseyde JF, Wolthers BJ: Steroid profile for urine: reference values. Clin Chem. 1989, 35: 2281-2284.PubMed Weykamp CW, Penders TJ, Schmidt NA, Borburgh AJ, van de Calseyde JF, Wolthers BJ: Steroid profile for urine: reference values. Clin Chem. 1989, 35: 2281-2284.PubMed
21.
go back to reference Fischer DA: The Quest Diagnostic Manual, endocrinology. Test selection and interpretation. Quest Diagnostics Incorporated. 2007, 105. Fischer DA: The Quest Diagnostic Manual, endocrinology. Test selection and interpretation. Quest Diagnostics Incorporated. 2007, 105.
22.
go back to reference Shackleton CHL, Marcos P: GC-MS steroid Profiling: Diagnosis of disorders affecting steroid synthesis and metabolism. The Encyclopedia of Mass Spectrometry. Edited by: Gross M, Caprioli R. 2006, Amsterdam: Elsevier, 789-813. Shackleton CHL, Marcos P: GC-MS steroid Profiling: Diagnosis of disorders affecting steroid synthesis and metabolism. The Encyclopedia of Mass Spectrometry. Edited by: Gross M, Caprioli R. 2006, Amsterdam: Elsevier, 789-813.
23.
go back to reference Kappas A, Bradlow HL, Gillette PN, Gallagher TF: Studies in porphyria. I. A defect in the reductive transformation of natural steroid hormones in the hereditary liver disease, acute intermittent porphyria. J Exp Med. 1972, 136: 1043-1053. 10.1084/jem.136.5.1043.CrossRefPubMedPubMedCentral Kappas A, Bradlow HL, Gillette PN, Gallagher TF: Studies in porphyria. I. A defect in the reductive transformation of natural steroid hormones in the hereditary liver disease, acute intermittent porphyria. J Exp Med. 1972, 136: 1043-1053. 10.1084/jem.136.5.1043.CrossRefPubMedPubMedCentral
24.
go back to reference Bradlow HL, Gillette PN, Gallagher TF, Kappas A: Studies in porphyria. II. Evidence for a deficiency of steroid delta-4-5-alpha-reductase activity in acute intermittent porphyria. J Exp Med. 1973, 138: 754-763. 10.1084/jem.138.4.754.CrossRefPubMedPubMedCentral Bradlow HL, Gillette PN, Gallagher TF, Kappas A: Studies in porphyria. II. Evidence for a deficiency of steroid delta-4-5-alpha-reductase activity in acute intermittent porphyria. J Exp Med. 1973, 138: 754-763. 10.1084/jem.138.4.754.CrossRefPubMedPubMedCentral
25.
go back to reference Christakoudi S, Deacon AC, Peters TJ, Taylor NF: Urinary steroid hormone metabolites in patients with porphyria. Endocrine Abstracts. 2003, 5: 241. Christakoudi S, Deacon AC, Peters TJ, Taylor NF: Urinary steroid hormone metabolites in patients with porphyria. Endocrine Abstracts. 2003, 5: 241.
26.
go back to reference Innala E, Bäckström T, Poromaa IS, Andersson C, Bixo M: Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle. Acta Obstet Gynecol Scand. 2012, 91: 1445-1452. 10.1111/j.1600-0412.2012.01536.x.CrossRefPubMed Innala E, Bäckström T, Poromaa IS, Andersson C, Bixo M: Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle. Acta Obstet Gynecol Scand. 2012, 91: 1445-1452. 10.1111/j.1600-0412.2012.01536.x.CrossRefPubMed
27.
go back to reference Christakoudi S, Cowan DA, Christakoudis G, Taylor NF: 21-hydroxylase deficiency in the neonate-trends in steroid anabolism and catabolism during the first weeks of life. J Steroid Biochem Mol Biol. 2013, 138: 334-347.CrossRefPubMed Christakoudi S, Cowan DA, Christakoudis G, Taylor NF: 21-hydroxylase deficiency in the neonate-trends in steroid anabolism and catabolism during the first weeks of life. J Steroid Biochem Mol Biol. 2013, 138: 334-347.CrossRefPubMed
28.
go back to reference Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L: The cortisol awakening response: more than a measure of HPA axis function. Neurosci Biobehav Rev. 2010, 35: 97-103. 10.1016/j.neubiorev.2009.12.011.CrossRefPubMed Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L: The cortisol awakening response: more than a measure of HPA axis function. Neurosci Biobehav Rev. 2010, 35: 97-103. 10.1016/j.neubiorev.2009.12.011.CrossRefPubMed
29.
go back to reference Stephens JK, Fisher PV, Marks GS: Porphyrin induction: equivalent effects of 5alphaH and 5betaH steroids in chick embryo liver cells. Science. 1977, 197 (4304): 659-660. 10.1126/science.877578.CrossRefPubMed Stephens JK, Fisher PV, Marks GS: Porphyrin induction: equivalent effects of 5alphaH and 5betaH steroids in chick embryo liver cells. Science. 1977, 197 (4304): 659-660. 10.1126/science.877578.CrossRefPubMed
Metadata
Title
Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control study
Authors
Oscar J Pozo
Josep Marcos
Andreu Fabregat
Rosa Ventura
Gregori Casals
Paula Aguilera
Jordi Segura
Jordi To-Figueras
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2014
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-9-54

Other articles of this Issue 1/2014

Orphanet Journal of Rare Diseases 1/2014 Go to the issue